1,074
Views
37
CrossRef citations to date
0
Altmetric
Research Paper

Seroprevalence of pertussis in China

Need to improve vaccination strategies

, , , , , , , & show all
Pages 192-198 | Received 18 Jun 2013, Accepted 02 Sep 2013, Published online: 09 Sep 2013

References

  • Kerr JR, Matthews RC. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis 2000; 19:77 - 88; http://dx.doi.org/10.1007/s100960050435; PMID: 10746492
  • de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010; 50:1339 - 45; http://dx.doi.org/10.1086/652281; PMID: 20370464
  • World Health Organization. Geneva: Programmes and projects/Immunization surveillance, assessment and monitoring/Vaccine-preventable diseases/Pertussis., Available at: http://www.who.int/immunization_monitoring/diseases/pertussis/en/index.html. [Last accessed March 23, 2013].
  • van Hoek AJCH, Campbell H, Amirthalingam G, Andrews N, Miller E. The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011. Euro Surveill 2013; 18:20414; PMID: 23470020
  • Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, Chavez G. California pertussis epidemic, 2010. J Pediatr 2012; 161:1091 - 6; http://dx.doi.org/10.1016/j.jpeds.2012.05.041; PMID: 22819634
  • Cherry JD. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease. N Engl J Med 2012; 367:785 - 7; http://dx.doi.org/10.1056/NEJMp1209051; PMID: 22894554
  • Wang J, Yang Y, Li J, Mertsola J, Arvilommi H, Shen X, He Q. Infantile pertussis rediscovered in China. Emerg Infect Dis 2002; 8:859 - 61; http://dx.doi.org/10.3201/eid0808.010442; PMID: 12141975
  • Wang L, Lei D, Zhang S. Acellular pertussis vaccines in China. Vaccine 2012; 30:7174 - 8; http://dx.doi.org/10.1016/j.vaccine.2012.10.009; PMID: 23084855
  • Zhu F. Pertussis booster vaccine in China. Hum Vaccin 2011; 7:272 - 5; http://dx.doi.org/10.4161/hv.7.2.13861; PMID: 21307651
  • Center for Disease Control and Prevention. Infectious Disease Report, Beijing, China. Available at: http://www.chinacdc.cn/tjsj/fdcrbbg/. [Last accessed March 24, 2013].
  • Guo Lichun LX. Huang Haitao, Xu Qingyang, Sun Zhengyi, Jiang Guangqi. Epidemiological investigation for an outbreak of pertussis in families. Chinese Journal of Vaccines and Immunization 2012; 18:180
  • Tan T, Halperin S, Cherry JD, Edwards K, Englund JA, Glezen P, Greenberg D, Rothstein E, Skowronski D. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005; 24:Suppl S83 - 6; http://dx.doi.org/10.1097/01.inf.0000160919.94330.1a; PMID: 15876933
  • Wirsing von König CH, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005; 24:Suppl S87 - 92; http://dx.doi.org/10.1097/01.inf.0000160920.75623.a3; PMID: 15876934
  • Anastassopoulou CG, Kafatos G, Nardone A, Andrews N, Pebody RG, Mossong J, Davidkin I, Gelb D, DE Ory F, Thierfelder W, et al. The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries. Epidemiol Infect 2009; 137:485 - 94; http://dx.doi.org/10.1017/S0950268808001155; PMID: 18694528
  • Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25:7866 - 72; http://dx.doi.org/10.1016/j.vaccine.2007.07.036; PMID: 17919788
  • Stroffolini T, Chiaramonte M, Craxì A, Franco E, Rapicetta M, Trivello R, De Mattia D, Mura I, Giammanco A, Rigo G, et al. Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination. J Infect 1991; 22:191 - 9; http://dx.doi.org/10.1016/0163-4453(91)91723-B; PMID: 2026895
  • Yeboah-Manu D, Röltgen K, Opare W, Asan-Ampah K, Quenin-Fosu K, Asante-Poku A, Ampadu E, Fyfe J, Koram K, Ahorlu C, et al. Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans. PLoS Negl Trop Dis 2012; 6:e1460; http://dx.doi.org/10.1371/journal.pntd.0001460; PMID: 22253937
  • Simonsen J, Strid MA, Mølbak K, Krogfelt KA, Linneberg A, Teunis P. Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiol Infect 2008; 136:895 - 902; http://dx.doi.org/10.1017/S0950268807009314; PMID: 17678562
  • Wang CQ, Zhu QR. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. Pediatr Infect Dis J 2011; 30:593 - 6; http://dx.doi.org/10.1097/INF.0b013e31820eaf88; PMID: 21422963
  • Zhang Q, Han F, Nie Q, Ren H, Zhang B, Liu Q, He Q, Shao Z. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. J Infect 2011; 63:441 - 6; http://dx.doi.org/10.1016/j.jinf.2011.07.018; PMID: 21864569
  • Zhang Q, Zheng H, Liu M, Han K, Shu J, Wu C, Xu N, He Q, Luo H. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis 2012; 12:138; http://dx.doi.org/10.1186/1471-2334-12-138; PMID: 22892100
  • Roberts M, Cropley I, Chatfield S, Dougan G. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA. Vaccine 1993; 11:866 - 72; http://dx.doi.org/10.1016/0264-410X(93)90363-3; PMID: 8356847
  • Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect Immun 1990; 58:7 - 16; PMID: 2294058
  • de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, Schellekens JF. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38:800 - 6; PMID: 10655388
  • Krause DS. Cross-section seroepidemiology of Bordetella pertussis. J Infect Dis 1996; 174:896; http://dx.doi.org/10.1093/infdis/174.4.896; PMID: 8843241
  • García-Corbeira P, Dal-Ré R, Aguilar L, García-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000; 18:2173 - 6; http://dx.doi.org/10.1016/S0264-410X(00)00029-3; PMID: 10717335
  • Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH, EU Pertstrain group. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011; 30:307 - 12; http://dx.doi.org/10.1007/s10096-010-1104-y; PMID: 21069406
  • Canthaboo C, Williams L, Xing DK, Corbel MJ. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines. Vaccine 2000; 19:637 - 43; http://dx.doi.org/10.1016/S0264-410X(00)00253-X; PMID: 11090715
  • Sato H, Sato Y. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan. Clin Infect Dis 1999; 28:Suppl 2 S124 - 30; http://dx.doi.org/10.1086/515063; PMID: 10447030
  • Mills KH, Ryan M, Ryan E, Mahon BP. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun 1998; 66:594 - 602; PMID: 9453614
  • Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005; 133:159 - 71; http://dx.doi.org/10.1017/S0950268804003012; PMID: 15724723
  • Halperin SA. The control of pertussis--2007 and beyond. N Engl J Med 2007; 356:110 - 3; http://dx.doi.org/10.1056/NEJMp068288; PMID: 17215528
  • Güriş D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230 - 7; http://dx.doi.org/10.1086/514776; PMID: 10451158
  • Lee GM, Lett S, Schauer S, LeBaron C, Murphy TV, Rusinak D, Lieu TA, Massachusetts Pertussis Study Group. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis 2004; 39:1572 - 80; http://dx.doi.org/10.1086/425006; PMID: 15578353
  • Baughman AL, Cortese MM, Slade BA. Incidence of Bordetella pertussis infection in adolescents and adults. Clin Infect Dis 2007; 44:149 - 50, author reply 150-1; http://dx.doi.org/10.1086/510081; PMID: 17143835
  • Mitka M. Age range widens for pertussis vaccine: boosters advised for adolescents and adults. JAMA 2006; 295:871 - 2; http://dx.doi.org/10.1001/jama.295.8.871; PMID: 16493092
  • Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24:Suppl S58 - 61; http://dx.doi.org/10.1097/01.inf.0000160914.59160.41; PMID: 15876927
  • Lavine JS, Bjørnstad ON, de Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 2012; 30:544 - 51; http://dx.doi.org/10.1016/j.vaccine.2011.11.065; PMID: 22119924
  • Wiese-Posselt M, Tertilt C, Zepp F. Vaccination recommendations for Germany. Dtsch Arztebl Int 2011; 108:771 - 9, quiz 780; PMID: 22163258
  • de Greeff SC, Lugnér AK, van den Heuvel DM, Mooi FR, de Melker HE. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. Vaccine 2009; 27:1932 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.01.106; PMID: 19368774
  • Lai FY, Thoon KC, Ang LW, Tey SH, Heng D, Cutter JL, Phoon MC, Chow VT. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Vaccine 2012; 30:3566 - 71; http://dx.doi.org/10.1016/j.vaccine.2012.03.059; PMID: 22475863
  • Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012; 308:2126 - 32; http://dx.doi.org/10.1001/jama.2012.14939; PMID: 23188029
  • Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012; 54:1730 - 5; http://dx.doi.org/10.1093/cid/cis287; PMID: 22423127
  • Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012; 54:318 - 27; http://dx.doi.org/10.1093/cid/cir836; PMID: 22156850
  • Isacson J, Trollfors B, Taranger J, Lagergård T. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J 1995; 14:517 - 21; http://dx.doi.org/10.1097/00006454-199506000-00009; PMID: 7667057
  • Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161:480 - 6; http://dx.doi.org/10.1093/infdis/161.3.480; PMID: 2313126
  • He Q, Viljanen MK, Olander RM, Bogaerts H, De Grave D, Ruuskanen O, Mertsola J. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J Infect Dis 1994; 170:705 - 8; http://dx.doi.org/10.1093/infdis/170.3.705; PMID: 8077734
  • Xu Y, Luo P, Wang L, Wei C, Hou Q, Zhang S. Development and validation of ELISA assays for determination of serum antibody against pertussis toxin, filamentous hemagglutinin, pertactin of B. pertussis. Chinese Journal of Vaccine and Immunization 2011; 17:205 - 8
  • Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol 2009; 16:303 - 11; http://dx.doi.org/10.1128/CVI.00372-08; PMID: 19109448

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.